Humanigen, Inc. (NASDAQ:HGEN – Get Rating) insider Dale Chappell bought 173,700 shares of Humanigen stock in a transaction that occurred on Wednesday, May 18th. The stock was bought at an average price of $1.96 per share, for a total transaction of $340,452.00. Following the completion of the acquisition, the insider now directly owns 8,066,575 shares […]
Humanigen (NASDAQ:HGEN – Get Rating) posted its earnings results on Thursday. The company reported ($0.32) earnings per share for the quarter, topping the consensus estimate of ($0.46) by $0.14, MarketWatch Earnings reports. Humanigen had a negative return on equity of 4,882.88% and a negative net margin of 6,582.73%. Shares of HGEN stock traded up $0.31 […]
Humanigen, Inc. (NASDAQ:HGEN – Get Rating) – Oppenheimer boosted their Q1 2022 earnings per share estimates for Humanigen in a report issued on Wednesday, March 16th. Oppenheimer analyst K. Degeeter now forecasts that the company will post earnings of ($0.34) per share for the quarter, up from their prior forecast of ($0.37). Oppenheimer also issued […]
Shares of Humanigen Inc (LON:HGEN – Get Rating) were up 0.4% during mid-day trading on Wednesday . The stock traded as high as GBX 102.20 ($1.33) and last traded at GBX 102 ($1.33). Approximately 106,771 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 198,130 shares. The stock […]
Humanigen, Inc. (NASDAQ:HGEN – Get Rating) insider Adrian Kilcoyne purchased 7,000 shares of the company’s stock in a transaction dated Tuesday, March 8th. The stock was purchased at an average price of $2.53 per share, with a total value of $17,710.00. The acquisition was disclosed in a filing with the SEC, which is available at […]